Part Description

LP422368-3   Comment on overall fetal aneuploidy risk
Noninvasive prenatal screening is used to assess fetal risk for various genetic conditions without requiring invasive maternal procedures such as amniocentesis or chorionic villus sampling. Cell-free DNA (cfDNA) in maternal plasma comes from both fetal and maternal sources, and various platforms have been developed using cfDNA to determine fetal risk. Natera's Panorama prenatal screening test uses a single blood sample from a pregnant woman, and using their proprietary informatics analysis method (NATUS), effectively subtracts the maternal genotype (from WBC DNA) from the cfDNA genotype and analyzes the remaining fetal cfDNA genotype for a variety of conditions including aneuploidy (e.g., Trisomy 21, Monosomy X) and microdeletions (e.g., 22q11.2 deletion). Specific results are typically reported for each individual condition and summarized for the report as a whole -- if the risk of any individual condition is high, the overall interpretation is "high risk," and if all the individual risks are low, the overall interpretation is "low risk." In addition, the genetic counselor who reviews the results may add specific interpretation details or follow-up recommendations to the report. Source: Regenstrief LOINC

LOINC Names Get Info

Fully-Specified Name
Comment on overall fetal aneuploidy risk:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosage of chromosome specific cf DNA
Long Common Name
Comment on overall fetal aneuploidy risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Short Name
Comment aneu risk WBC.DNA+cfDNA
Display Name
Comment on overall fetal aneuploidy risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA)
Consumer Name Alpha Get Info
Comment on overall fetal aneuploidy risk

Part Model Get Info

  • Component
    Comment on overall fetal aneuploidy risk
    LP422368-3
    • Analyte
      Comment on overall fetal aneuploidy risk
      LP422368-3
      • Component Numerator
        Comment on overall fetal aneuploidy risk
        LP422368-3
        • Component Numerator Core
          Comment on overall fetal aneuploidy risk
          LP422368-3
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Txt
    LP6885-0
  • Time
    Pt
    LP6960-1
  • System
    WBC.DNA+Plas.cfDNA
    LP185797-0
    • System Core
      WBC.DNA+Plas.cfDNA
      LP185797-0
    • Super System
      NULL
       
  • Scale
    Nar
    LP7749-7
  • Method
    Dosage of chromosome specific cf DNA
    LP172871-8

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.70
Last Updated
Version 2.70 (ADD)
Order vs. Observation
Observation

Member of these Panels

LOINCLong Common Name
96977-4Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Komentář Aneuploidie celkové riziko u plodu:Text:Časový bod:DNA volná cirkulující (cfDNA) a DNA leukocytů (WBC DNA):Narativní:Dávkování chromozomálně specifické cfDNA
el-GRGreek (Greece)Σχόλιο επί του συνολικού κινδύνου εμβρυϊκής ανευπλοειδίας:Txt:Pt:Αριθμός λευκών αιμοσφαιρίων.DNA+Πλάσμα.cfDNA:Nar:Δοσολογία ειδικού χρωμοσωμικού cf DNA
Synonyms: MOLPATH Nar Pt Txt Αριθμός λευκών αιμοσφαιρίων Αριθμός λευκών αιμοσφαιρίων.DNA+Πλάσμα.cfDNA Δοσολογία ειδικού χρωμοσωμικού cf DNA Πλάσμα Πλάσμα.cfDNA Σχόλιο Σχόλιο επί του συνολικού κινδύνου εμβρυϊκής ανευπλοειδίας
es-ESSpanish (Spain)Comentario sobre el riesgo general de aneuploidía fetal:Texto:Punto temporal:ADN en plasma libre de células y leucocitos:Narrativo:Dosificación de ADN ccf de cromosoma específico
es-MXSpanish (Mexico)Comente sobre el riesgo general de aneuploidía fetal:TXT:Punto temporal:WBC.DNA + Plas.cfDNA:Narrativo:Dosificación de ADN cf cromosómico específico
fr-FRFrench (France)Risque global d'aneuploïdie foetale (Commentaire):Texte:Ponctuel:Leucocytes ADN+Plasma avec ADN libre circulant:Résultat textuel:Dosage d'ADN libre circulant spécifiques aux chromosomes
it-ITItalian (Italy)Commento su rischio generale aneuploidaia fetale:Txt:Pt:WBC.DNA+Plas.cfDNA:Nar:Dosaggio di DNA libero fetale circolante cromosoma specifico
Synonyms: DNA libero circolante nel plasma Dosaggio di DNA libero fetale circolante cromosoma Globuli bianchi Globuli bianchi+DNA libero circolante nel plasma Patologia molecolare Plasma Punto nel tempo (episodio) Testo
zh-CNChinese (China)关于无创性产前胎儿非整倍体性风险的遗传咨询师意见:文本型属性:时间点:白细胞.DNA+血浆.cfDNA:叙述型:染色体特异性 cfDNA 剂量测定
Synonyms: WBC.DNA+血浆.cfDNA;白细胞.DNA 与血浆.cfDNA;白细胞.DNA+血浆循环 cfDNA;白细胞.DNA+血浆循环 DNA;白细胞.DNA+循环游离核酸;白细胞.DNA+血浆游离 DNA;白细胞.DNA+血浆无细胞 DNA WBC;WBCs;白血球;白血细胞 全面;整体;总体情况 关于无创性(无创型、无创、非侵入性)产前胎儿非整倍体性(非整倍体型、非整倍体、异倍体、非整倍性、异倍性、非整倍态、异倍体性)的遗传咨询师(遗传病辅导员、基因咨询师、遗传谘询师、基因谘询师)意见(评论、解释、注释、注解、点评) 分子病理学;分子病理学试验 叙述;叙述性文字;报告;报告型;文字叙述;文本叙述型;文本描述;文本描述型 备注 备注;评论;注解;说明;评语 意见 文本;文本型;文本属性 时刻;随机;随意;瞬间 染色体特异性 cf DNA 剂量测定;染色体特异性游离循环 DNA 剂量测定;染色体特异性循环游离 DNA 剂量测定;Cell Free DNA 注解 特异 特异性的 特异的 短评 血浆循环 cfDNA;血浆循环 DNA;循环游离核酸;血浆游离 DNA;血浆无细胞 DNA;Free circulating/Cell-free DNA;Free circulating DNA 解说 解释 评定 评注 评论 评语 说明

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=96980-8